# Trade Mark Journal No.2026/009 27 February 2026

## WO0000001901831 (5)

Office of origin: United States of America

Date of International Registration:14 January 2026
Date of designation in the UK: 14 January 2026

International priority date claimed: 15 July 2025 (United States of America) (99284130)

Class 5
  Pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for use in oncology.

Immunome, Inc.

Representative: Joyce Liou Morrison & Foerster LLP, 425 Market Street, San Francisco CA 94105, UNITED STATES OF AMERICA